Novel FABP4+C1q+ macrophages enhance antitumor immunity and associated with response to neoadjuvant pembrolizumab and chemotherapy in NSCLC via AMPK/JAK/STAT axis.

Details

Language :

English

ISSN :

20414889

Volume :

15

Issue :

10

Database :

Complementary Index

Journal :

Cell Death & Disease

Publication Type :

Academic Journal

Accession number :

180934347

Full Text :

https://doi.org/10.1038/s41419-024-07074-x